168 related articles for article (PubMed ID: 22530128)
1. Combined RASSF1A and RASSF2A Promoter Methylation Analysis as Diagnostic Biomarker for Bladder Cancer.
Meng W; Huebner A; Shabsigh A; Chakravarti A; Lautenschlaeger T
Mol Biol Int; 2012; 2012():701814. PubMed ID: 22530128
[TBL] [Abstract][Full Text] [Related]
2. Promoter methylation status of
Atmaca HN; Gun S; Onal M; Tural S
Nucleosides Nucleotides Nucleic Acids; 2024 Jun; ():1-13. PubMed ID: 38830238
[TBL] [Abstract][Full Text] [Related]
3. Methylation in promoter regions of PITX2 and RASSF1A genes in association with clinicopathological features in breast cancer patients.
Jezkova E; Kajo K; Zubor P; Grendar M; Malicherova B; Mendelova A; Dokus K; Lasabova Z; Plank L; Danko J
Tumour Biol; 2016 Oct; ():. PubMed ID: 27744628
[TBL] [Abstract][Full Text] [Related]
4. Methylation of RASSF1A, RASSF2A, and HIN-1 is associated with poor outcome after radiotherapy, but not surgery, in oral squamous cell carcinoma.
Huang KH; Huang SF; Chen IH; Liao CT; Wang HM; Hsieh LL
Clin Cancer Res; 2009 Jun; 15(12):4174-80. PubMed ID: 19509163
[TBL] [Abstract][Full Text] [Related]
5. Hypermethylation of RAS effector related genes and DNA methyltransferase 1 expression in endometrial carcinogenesis.
Liao X; Siu MK; Chan KY; Wong ES; Ngan HY; Chan QK; Li AS; Khoo US; Cheung AN
Int J Cancer; 2008 Jul; 123(2):296-302. PubMed ID: 18404674
[TBL] [Abstract][Full Text] [Related]
6. CpG island promoter hypermethylation of a novel Ras-effector gene RASSF2A is an early event in colon carcinogenesis and correlates inversely with K-ras mutations.
Hesson LB; Wilson R; Morton D; Adams C; Walker M; Maher ER; Latif F
Oncogene; 2005 Jun; 24(24):3987-94. PubMed ID: 15806169
[TBL] [Abstract][Full Text] [Related]
7. Impact of
Jezkova E; Zubor P; Kajo K; Grendar M; Dokus K; Adamkov M; Lasabova Z; Plank L; Danko J
Oncol Lett; 2017 Jul; 14(1):758-766. PubMed ID: 28693231
[TBL] [Abstract][Full Text] [Related]
8. Aberrant promoter methylation and silencing of RASSF2A gene in cervical cancer.
Zhang X; Ma Y; Wu Y; Lin L; Ma X; Zhang Y
J Obstet Gynaecol Res; 2014 May; 40(5):1375-81. PubMed ID: 24605823
[TBL] [Abstract][Full Text] [Related]
9. Aberrant methylation of RASSF2A in tumors and plasma of patients with epithelial ovarian cancer.
Wu Y; Zhang X; Lin L; Ma XP; Ma YC; Liu PS
Asian Pac J Cancer Prev; 2014; 15(3):1171-6. PubMed ID: 24606436
[TBL] [Abstract][Full Text] [Related]
10. Ras association domain family 1A: a promising prognostic marker in recurrent nonmuscle invasive bladder cancer.
Kim JS; Chae Y; Ha YS; Kim IY; Byun SS; Yun SJ; Kim WJ
Clin Genitourin Cancer; 2012 Jun; 10(2):114-20. PubMed ID: 22382007
[TBL] [Abstract][Full Text] [Related]
11. The RASSF gene family members RASSF5, RASSF6 and RASSF7 show frequent DNA methylation in neuroblastoma.
Djos A; Martinsson T; Kogner P; Carén H
Mol Cancer; 2012 Jun; 11():40. PubMed ID: 22695170
[TBL] [Abstract][Full Text] [Related]
12. The RASSF proteins in cancer; from epigenetic silencing to functional characterization.
Richter AM; Pfeifer GP; Dammann RH
Biochim Biophys Acta; 2009 Dec; 1796(2):114-28. PubMed ID: 19344752
[TBL] [Abstract][Full Text] [Related]
13. Methylation of RASSF1A gene promoter and the correlation with DNMT1 expression that may contribute to esophageal squamous cell carcinoma.
Du Z; Ma K; Sun X; Li A; Wang H; Zhang L; Lin F; Feng X; Song J
World J Surg Oncol; 2015 Apr; 13():141. PubMed ID: 25886188
[TBL] [Abstract][Full Text] [Related]
14. High frequency of promoter hypermethylation of RASSF1A and p16 and its relationship to aflatoxin B1-DNA adduct levels in human hepatocellular carcinoma.
Zhang YJ; Ahsan H; Chen Y; Lunn RM; Wang LY; Chen SY; Lee PH; Chen CJ; Santella RM
Mol Carcinog; 2002 Oct; 35(2):85-92. PubMed ID: 12325038
[TBL] [Abstract][Full Text] [Related]
15. Correlation between hypermethylation of the RASSF2A promoter and K-ras/BRAF mutations in microsatellite-stable colorectal cancers.
Park HW; Kang HC; Kim IJ; Jang SG; Kim K; Yoon HJ; Jeong SY; Park JG
Int J Cancer; 2007 Jan; 120(1):7-12. PubMed ID: 17013898
[TBL] [Abstract][Full Text] [Related]
16. Relationship between the expression of RASSF1A protein and promoter hypermethylation of RASSF1A gene in bladder tumor.
Hu J; Li H; Shi T; Ma X; Wang B; Xu H; Ai X; Ju Z; Wang C; Zhang G; Zhang X
J Huazhong Univ Sci Technolog Med Sci; 2008 Apr; 28(2):182-4. PubMed ID: 18480993
[TBL] [Abstract][Full Text] [Related]
17. Applicability of HIN-1, MGMT and RASSF1A promoter methylation as biomarkers for detecting field cancerization in breast cancer.
Spitzwieser M; Holzweber E; Pfeiler G; Hacker S; Cichna-Markl M
Breast Cancer Res; 2015 Sep; 17(1):125. PubMed ID: 26370119
[TBL] [Abstract][Full Text] [Related]
18. Decreased expression and frequent promoter hypermethylation of RASSF2 and RASSF6 correlate with malignant progression and poor prognosis of gastric cardia adenocarcinoma.
Guo W; Dong Z; Guo Y; Shen S; Guo X; Kuang G; Yang Z
Mol Carcinog; 2016 Nov; 55(11):1655-1666. PubMed ID: 26456015
[TBL] [Abstract][Full Text] [Related]
19. DNA methylation patterns in bladder cancer and washing cell sediments: a perspective for tumor recurrence detection.
Negraes PD; Favaro FP; Camargo JL; Oliveira ML; Goldberg J; Rainho CA; Salvadori DM
BMC Cancer; 2008 Aug; 8():238. PubMed ID: 18702824
[TBL] [Abstract][Full Text] [Related]
20. Aberrant methylation of RASSF4/AD037 in nasopharyngeal carcinoma.
Chow LS; Lo KW; Kwong J; Wong AY; Huang DP
Oncol Rep; 2004 Oct; 12(4):781-7. PubMed ID: 15375500
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
